Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Psychiatric Quarterly
Published in: Psychiatric Quarterly 1/2011

01-03-2011 | Original Paper

Sleepwalking, A Possible Side Effect of Antipsychotic Medication

Author: Mary V. Seeman

Published in: Psychiatric Quarterly | Issue 1/2011

Login to get access

Abstract

Two case examples and a review of the sleep literature illustrate the potential of antipsychotic medication to trigger sleepwalking episodes in the context of schizophrenia. Causative hypotheses are briefly reviewed, as well as risk factors, differential diagnosis, and management. Sleepwalking may contribute to delusions, aggression, and accidental suicide. It is important to investigate sleep disorders in schizophrenia. They are not rare and may contribute to behavior that increases the stigma and isolation of individuals with schizophrenia.
Literature
1.
Shatkin JP, Feinfield K, Strober M. The misinterpretation of a non-REM sleep parasomnia as suicidal behavior in an adolescent. Sleep and Breathing 6:175–179, 2002PubMedCrossRef
2.
Cohrs S. Sleep disturbances in patients with schizophrenia: Impact and effect of antipsychotics. Central Nervous System Drugs 22:939–962, 2008
3.
Hublin C, Kaprio J, Partinen M, et al. Prevalence and genetics of sleepwalking: A population-based twin study. Neurology 48:177–181, 1997PubMed
4.
Lam SP, Fong SY, Ho CK, et al. Parasomnia among psychiatric outpatients: A clinical, epidemiologic, cross-sectional study. Journal of Clinical Psychiatry 69:1374–1382, 2008PubMedCrossRef
5.
Kales JD, Humphrey FJ, Martin ED, et al. Clinical characteristics of patients with sleepwalking: Further studies. Sleep Research 7:192, 1978
6.
Cartwright R. Sleepwalking violence: A sleep disorder, a legal dilemma, and a psychological challenge. American Journal of Psychiatry 161:1149–1158, 2004PubMedCrossRef
7.
Hafeez ZH, Kalinowski CM. Somnambulism induced by quetiapine: Two case reports and a review of the literature. Central Nervous System Spectrum 12:910–912, 2007
8.
Juszczaka GR, Swiergiela AH. Serotonergic hypothesis of sleepwalking. Medical Hypotheses 64:28–32, 2005CrossRef
9.
Kawashima T, Yamada S. Paroxetine-induced somnambulism. Journal of Clinical Psychiatry 64:483, 2003PubMedCrossRef
10.
Jindal RD, Friedman ES, Berman SR, et al. Effects of sertraline on sleep architecture in patients with depression. Journal of Clinical Psychopharmacology 23:540–548, 2003PubMedCrossRef
11.
Moldofsky H, Gilbert R, Lue FA, et al. Sleep-related violence. Sleep 18:731–739, 1995PubMed
12.
Dolder CR, Nelson MH. Hypnosedative-induced complex behaviours: Incidence, mechanisms and management. Central Nervous System Drugs 22:1021–1036, 2008
13.
Espa F, Ondze B, Deglise P, et al. Sleep architecture, slow wave activity, and sleep spindles in adult patients with sleepwalking and sleep terrors. Clinical Neurophysiology 111:929–939, 2000PubMedCrossRef
14.
Pilon M, Zadra A, Joncas S, Montplaisir J. Hypersynchronous delta waves and somnambulism: Brain topography and effect of sleep deprivation. Sleep 29:77–84, 2006PubMed
15.
Pilon M, Montplaisir J, Zadra A. Precipitating factors of somnambulism: Impact of sleep deprivation and forced arousals. Neurology 70:2284–2290, 2008PubMedCrossRef
16.
Hughes JR. A review of sleepwalking (somnambulism): The enigma of neurophysiology and polysomnography with differential diagnosis of complex partial seizures. Epilepsy Behavior 11:483–491, 2007PubMedCrossRef
17.
Tassinari CA, Cantalupo G, Högl B, et al. Neuroethological approach to frontolimbic epileptic seizures and parasomnias: The same central pattern generators for the same behaviours. Revue Neurologique (Paris) 165:762–768, 2009CrossRef
18.
Tinuper P, Provini F, Bisulli F, et al. Movement disorders in sleep: Guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep. Sleep Medicine Reviews 11:255–267, 2007PubMedCrossRef
19.
Jiménez-Genchi A, Díaz-Galviz JL, García-Reyna JC, et al. Coexistence of epileptic nocturnal wanderings and an arachnoid cyst. Journal of Clinical Sleep Medicine 3:399–401, 2007PubMed
20.
Pressman MR. Factors that predispose, prime and precipitate NREM parasomnias in adults: Clinical and forensic implications. Sleep Medicine Reviews 11:5–30, 2007PubMedCrossRef
21.
Guilleminault C, Kirisoglu C, Bao G, et al. Adult chronic sleepwalking and its treatment based on polysomnography. Brain 128:1062–1069, 2005PubMedCrossRef
22.
Morishita S. Clonazepam as a therapeutic adjunct to improve the management of depression: A brief review. Human Psychopharmacology 24:191–198, 2009PubMedCrossRef
23.
Harris M, Grunstein RR. Treatments for somnambulism in adults: Assessing the evidence. Sleep Medicine Reviews 13:295–297, 2009PubMedCrossRef
24.
Landry P, Warnes H, Nielsen T, Montplaisir J. Somnambulistic-like behaviour in patients attending a lithium clinic. International Clinical Psychopharmacology 14:173–175, 1999PubMed
25.
Charney DS, Kales A, Soldatos CR, et al. Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment. British Journal of Psychiatry 135:418–424, 1979PubMedCrossRef
26.
Price LH, Charney DS, Delgado PL, et al. Lithium and serotonin function: Implications for the serotonin hypothesis of depression. Psychopharmacology 100:3–12, 1990PubMedCrossRef
27.
Wegener G, Bandpey Z, Heiberg IL, et al. Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: Neurochemical and behavioural studies in the rat. Psychopharmacology 166:188–194, 2003PubMed
28.
Hedman C, Pohjasvaara T, Tolonen U, et al. Parasomnias decline during pregnancy. Acta Neurologica Scandinavica 105:209–214, 2002PubMedCrossRef
29.
Eichling PS, Sahni J. Menopause related sleep disorders. Journal of Clinical Sleep Medicine 1:291–300, 2005PubMed
30.
Moline ML, Broch L, Zak R, et al. Sleep in women across the life cycle from adulthood through menopause. Sleep Medicine Reviews 7:155–177, 2003PubMedCrossRef
31.
Tantrakul V, Guilleminault C. Chronic sleep complaints in premenopausal women and their association with sleep-disordered breathing. Lung 187:82–92, 2009PubMedCrossRef
32.
33.
Lecendreux M, Bassetti C, Dauvilliers Y, et al. HLA and genetic susceptibility to sleepwalking. Molecular Psychiatry 8:114–117, 2003PubMedCrossRef
34.
Oudiette D, Leu S, Pottier M, et al. Dreamlike mentations during sleepwalking and sleep terrors in adults. Sleep 32:1621–1627, 2009PubMed
35.
Pillmann F. Complex dream-enacting behavior in sleepwalking. Psychosomatic Medicine 71:231–234, 2009PubMedCrossRef
36.
Mahowald MW, Schenck CH. Insights from studying human sleep disorders. Nature 437:1279–1285, 2005PubMedCrossRef
37.
Schenck C, Mahowald M: Long-term nightly benzodiazepine treatment of injurious parasomnias and other disorders of disturbed nocturnal sleep in 170 adults. American Journal of Medicine 100:333–337, 1996PubMedCrossRef
38.
Bornemann MA, Mahowald MW, Schenck CH. Parasomnias: Clinical features and forensic implications. Chest 130:605–610, 2006PubMedCrossRef
39.
Ebrahim IO, Fenwick P. Sleep-related automatism and the law. Medicine, Science and the Law 48:124–136, 2008CrossRef
40.
Pressman MR, Mahowald MW, Schenck CH, et al. Sleep-related automatism and the law. Medicine, Science and the Law 49:139–143, 2009CrossRef
41.
Riva MA, Sironi VA Tremolizzo L, et al. Sleepwalking in Italian operas: A window on popular and scientific knowledge on sleep disorders in the 19th Century. European Neurology 63:116–121, 2010PubMedCrossRef
42.
Pressman MR. Disorders of arousal from sleep and violent behavior: The role of physical contact and proximity. Sleep 30:1039–1047, 2007PubMed
43.
Mahowald MW, Schenck CH, Goldner M, et al. Parasomnia pseudo-suicide. Journal of Forensic Science 48:1158–1162, 2003
Metadata
Title
Sleepwalking, A Possible Side Effect of Antipsychotic Medication
Author
Mary V. Seeman
Publication date
01-03-2011
Publisher
Springer US
Published in
Psychiatric Quarterly / Issue 1/2011
Print ISSN: 0033-2720
Electronic ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-010-9149-8

Other articles of this Issue 1/2011

Psychiatric Quarterly 1/2011 Go to the issue

Original Paper

Social Value of Supported Employment for Psychosocial Program Participants

Original Paper

Characteristics of Assaultive Psychiatric Patients: 20-Year Analysis of the Assaultive Staff Action Program (ASAP)

Original Paper

Evidence-Based Recommendations for the Treatment of Aggression in Pediatric Patients with Attention Deficit Hyperactivity Disorder

Original Paper

EMDR Treatment in People with Mild ID and PTSD: 4 Cases

Original Paper

Characteristics of Staff Victims of Psychiatric Patient Assaults: 20-Year Analysis of the Assaulted Staff Action Program

Original Paper

The Relationship Between the Medical Director and the Executive Director: Guidelines for Success